Affinity Selection Technologies for Hit Finding: Current State of the Art

cancel
Showing results for 
Search instead for 
Did you mean: 

Affinity Selection Technologies for Hit Finding: Current State of the Art

ACS Webinars Hub Placeholder Image.png
Published on ‎08-19-2022 03:44 PM by | Updated on ‎08-19-2022 03:46 PM

The identification of new chemical matter represents a critical step in the early stages of a drug discovery project. An increasingly broad collection of platforms are available to perform this task, some more suited to small, focused screening sets and some more adapted to very large screening sets. Recently traditional high-throughput biochemical assays with a functional read-out have been supplemented by a range of assays based on biophysical methods that address the physical interaction between ligand and protein, but are agnostic of the functional consequence (if any). 
 
In this webinar we will focus on those techniques that seek to identify small molecule binders to target proteins using such ‘affinity selection’ methods. We will discuss the current state of the art for screening of fragments, small screening collections, and ultra-large diversity collections using techniques such as NMR, affinity selection mass spectrometry, and DNA-encoded library screens. 
 
 
Key Learning Objectives:
  • Review techniques that seek to identify small molecule binders to target proteins using such ‘affinity selection’ methods  
  • Explore the current state of the art for screening of fragments, small screening collections, and ultra-large diversity collections using techniques such as NMR, affinity selection mass spectrometry, and DNA-encoded library screens. 
Who Should Attend:
  • Drug discovery scientists in academia
  • Drug discovery scientists in biotech and pharmaceutical industry 
  • Chemists 
  • Biologists 
  • Pharmacologists  
  • Bioanalytical Scientists
  • Biophysical Scientists

Brought to you by:

%7B9fc77079-6f46-4be9-8b9c-3918e8d55a59%7D_WuXiSTA-logo 

Speakers:

%7Bbab55fe6-163e-448b-9a49-3f2a400af5ad%7D_2022-9-8-Dave-Madge-speaker

Dave Madge
Vice President
WuXi AppTec



%7B4506b2d6-70f8-4829-8f7f-8d5cee435b2c%7D_2022-9-8-Alex-Satz-speakerAlex Satz
Senior Director, DEL Strategy
WuXi AppTec



%7Bba7e4148-b479-43b0-8376-cdcaba0b486e%7D_2022-9-8-Grzegorz-Popowicz-speakerGrzegorz Popowicz
Head, Helmholtz Institute



 

%7B93ead0b1-e7e1-467d-acb4-668d2a74f792%7D_2022-9-8-Penny-Jia-speaker

Penny Jia
AS-MS Project Leader
WuXi AppTec



%7B2ca08302-9b4a-4f05-9567-32b5c3f9f223%7D_AnnThayer_100x100

Ann Thayer
Contributing Editor
C&EN Media Group



Event has ended
You can no longer attend this event.

Start:
Thu, Sep 8, 2022 11:00 AM EDT
End:
Thu, Sep 8, 2022 12:00 PM EDT
<a href='https://connect.acspubs.org/CENWebinar_WuXi_9_8_22?partnerref=WebinarsHub'>Register</a>
Labels (2)
0 Kudos
0 Comments